COMP <GO>
EPC vs TSLA // 10Y YIELD & FRED MACRO BETA
Edgewell Personal Care Company (NYSE) VS. Tesla, Inc. (NASDAQ) • 15-METRIC TALLY: EPC 6
— TSLA 6
■ METRIC PARITY
LAST: $28.57 (+3.25%) • MKT CAP: $1.32B
macro-sensitivity
—
LAST: $403.30 (-0.23%) • MKT CAP: $1.59T
macro-sensitivity
1.89
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EPC VS. TSLA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EPC | TSLA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.60% | 19.29% | +22.31 | EPC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.50% | 3.39% | -0.89 | TSLA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 29.4x | 199.0x | -169.64 | EPC | /valuation <GO> |
| Free Cash Flow Yield | 8.99% | 0.21% | +8.78 | EPC | /fcf-yield <GO> |
| Operating Margin | 4.30% | 3.35% | +0.95 | EPC | /operating-margins <GO> |
| Net Profit Margin | 1.10% | 3.11% | -2.01 | TSLA | /net-margins <GO> |
| Revenue Growth (YoY) | -1.30% | 8.30% | -9.60 | TSLA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.23% | 0.00% | +2.23 | EPC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.58 | 15.35 | -13.77 | TSLA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | EPC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 8.72% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.6 | 56.6 | -1.01 | TSLA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 1.89 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 48.2x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.32B | $1.59T | -$1.59T | TSLA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EPC REV | TSLA REV | EPC GROSS % | TSLA GROSS % | EPC FCF | TSLA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.22B | $94.83B | 41.6% | 18.0% | $118.4M | $6.22B |
| FY 2024 | $2.25B | $97.69B | 42.4% | 17.9% | -$231.0M | $3.58B |
| FY 2023 | $2.25B | $96.77B | — | 18.3% | -$216.1M | $4.36B |
| FY 2022 | — | $81.46B | — | 25.6% | — | $7.57B |
| FY 2021 | — | $53.82B | — | 25.3% | — | $5.01B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EPC // BETA —
TSLA // BETA 1.89